View Filing Data

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2014	Jul. 25, 2014
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q2
Trading Symbol	VRNG
Entity Common Stock, Shares Outstanding		92,545,862
Entity Registrant Name	Vringo Inc
Entity Central Index Key	0001410428
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 31,654	$ 33,586
Assets held for sale	0	787
Deposits with courts	2,304	0
Other current assets	224	455
Total current assets	34,182	34,828
Property and equipment, at cost, net of $348 and $134 accumulated depreciation, as of June 30, 2014 and December 31, 2013, respectively	161	230
Intangible assets, net	20,823	22,748
Goodwill	65,757	65,757
Other assets	1,034	247
Total assets	121,957	123,810
Current liabilities
Accounts payable and accrued expenses	4,582	5,146
Accrued employee compensation	36	299
Derivative warrant liabilities	89	43
Total current liabilities	4,707	5,488
Long-term liabilities
Derivative warrant liabilities	3,015	4,040
Other liabilities	69	0
Commitments and contingencies (Note 10)
Stockholders' equity
Series A Convertible Preferred stock, $0.01 par value per share; 5,000,000 authorized; none issued and outstanding	0	0
Common stock, $0.01 par value per share 150,000,000 authorized; 92,545,862 and 84,502,653 issued and outstanding as of June 30, 2014 and December 31, 2013, respectively	925	845
Additional paid-in capital	210,427	189,465
Accumulated deficit	(97,186)	(76,028)
Total stockholders' equity	114,166	114,282
Total liabilities and stockholders' equity	$ 121,957	$ 123,810

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2014	Dec. 31, 2013
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 348	$ 134
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	150,000,000	150,000,000
Common stock, issued	92,545,862	84,502,653
Common stock, outstanding	92,545,862	84,502,653
Series A convertible preferred stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue	$ 800	$ 1,100	$ 1,050	$ 1,100
Costs and Expenses*
Operating legal costs	5,982	4,790	10,857	10,189
Amortization of intangibles	968	839	1,925	1,678
Research and development	217	467	442	737
General and administrative	3,986	3,759	8,004	7,750
Total operating expenses	11,153	9,855	21,228	20,354
Operating loss from continuing operations	(10,353)	(8,755)	(20,178)	(19,254)
Non-operating income, net	21	17	22	32
Gain (loss) on revaluation of warrants	348	(1,491)	(728)	(1,866)
Issuance of warrants	(65)	0	(65)	0
Loss from continuing operations before income taxes	(10,049)	(10,229)	(20,949)	(21,088)
Income tax expense	0	0	0	0
Loss from continuing operations	(10,049)	(10,229)	(20,949)	(21,088)
Loss from discontinued operations before income taxes*	0	(709)	(209)	(1,798)
Income tax expense	0	(2)	0	(18)
Loss from discontinued operations	0	(711)	(209)	(1,816)
Net loss	$ (10,049)	$ (10,940)	$ (21,158)	$ (22,904)
Basic
Loss per share from continuing operations	$ (0.12)	$ (0.12)	$ (0.24)	$ (0.26)
Loss per share from discontinued operations	(0.00)	(0.01)	(0.00)	(0.02)
Total net loss per share	(0.12)	(0.13)	(0.24)	(0.28)
Diluted
Loss per share from continuing operations	(0.12)	(0.12)	(0.24)	(0.26)
Loss per share from discontinued operations	(0.00)	(0.01)	(0.00)	(0.02)
Total net loss per share	$ (0.12)	$ (0.13)	$ (0.24)	$ (0.28)
Weighted-average number of shares outstanding during the period:
Basic	87,210,483	82,739,447	86,337,006	82,552,710
Diluted	88,515,948	82,739,447	86,337,006	82,552,710
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	$ 3,018	$ 3,022	$ 5,818	$ 6,116
Operating legal costs [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	385	301	728	595
Research and Development [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	108	114	215	248
General and Administrative [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	2,525	2,515	4,724	5,043
Discontinued Operations [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	$ 0	$ 92	$ 151	$ 230

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2012	$ 148,332	$ 819	$ 171,108	$ (23,595)
Exercise of stock options and vesting of restricted stock units (“RSU”)	153	10	143	0
Exercise of warrants	250	1	249	0
Conversion of derivative warrants into equity warrants	3,748	0	3,748	0
Stock-based compensation	6,116	0	6,116	0
Net loss for the period	(22,904)	0	0	(22,904)
Balance at Jun. 30, 2013	135,695	830	181,364	(46,499)
Balance at Dec. 31, 2013	114,282	845	189,465	(76,028)
Exercise of stock options and vesting of restricted stock units (“RSU”)	2,160	16	2,144	0
Issuance of warrants (Note 8)	65	0	65	0
Exercise of warrants	12,999	64	12,935	0
Stock-based compensation	5,818	0	5,818	0
Net loss for the period	(21,158)	0	0	(21,158)
Balance at Jun. 30, 2014	$ 114,166	$ 925	$ 210,427	$ (97,186)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities
Net loss	$ (21,158)	$ (22,904)
Adjustments to reconcile net cash flows used in operating activities:
Depreciation and amortization	2,139	2,567
Stock-based compensation	5,818	6,116
Issuance of warrants	65	0
Assignment of patents	0	(100)
Change in fair value of warrants	728	1,866
Exchange rate loss (gain), net	(35)	4
Changes in current assets and liabilities
Decrease in other current assets	231	73
Increase (decrease) in payables and accruals	(743)	1,412
Net cash used in operating activities	(12,955)	(10,966)
Cash flows from investing activities
Acquisition of property and equipment	(145)	(31)
Increase in short-term investments	0	(3,120)
Decrease (increase) in deposits	(2,304)	8
Net cash used in investing activities	(2,449)	(3,143)
Cash flows from financing activities
Exercise of stock options	2,160	153
Exercise of warrants	11,292	174
Cash provided by financing activities	13,452	327
Effect of exchange rate changes on cash and cash equivalents	20	10
Decrease in cash and cash equivalents	(1,932)	(13,772)
Cash and cash equivalents at beginning of period	33,586	56,960
Cash and cash equivalents at end of period	31,654	43,188
Supplemental disclosure of cash flows information
Income taxes paid	0	3
Non-cash investing and financing transactions
Non-cash acquisition of cost method investment	787	0
Conversion of derivative warrants into common stock	1,707	76
Conversion of derivative warrants into equity warrants	$ 0	$ 3,748

General

6 Months Ended

Jun. 30, 2014

General [Abstract]

General

Note 1. General

Vringo, Inc., together with its consolidated subsidiaries (“Vringo” or the “Company”), is engaged in the development and monetization of intellectual property worldwide. The Company's intellectual property portfolio consists of over 600 patents and patent applications covering telecom infrastructure, internet search and mobile technologies. The Company’s patents and patent applications have been developed internally or acquired from third parties. Prior to December 31, 2013, the Company operated a global platform for the distribution of mobile social applications and the services that it developed. On February 18, 2014, the Company executed the sale of its mobile social application business to InfoMedia Services Limited (“InfoMedia”), receiving an 8.25% ownership interest as consideration (Note 4).

Accounting and Reporting Policies

6 Months Ended

Jun. 30, 2014

Accounting Policies [Abstract]

Accounting and Reporting Policies

Note 2. Accounting and Reporting Policies

(a) Basis of presentation and principles of consolidation

The accompanying interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2013. The results of operations for the three month and six month periods ended June 30, 2014 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.

(b) Use of estimates

The preparation of accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, the valuation of goodwill, deferred tax assets and liabilities, income tax uncertainties and other contingencies.

(c) Translation into U.S. dollars

The Company conducts certain transactions in foreign currencies, which are recorded at the exchange rate as of the transaction date. All exchange gains and losses occurring from the remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected as non-operating income or expense in the consolidated statements of operations.

(d) Cash and cash equivalents

The Company invests its cash in money market funds with financial institutions. The Company has established guidelines relating to diversification and maturities of its investments in order to minimize credit risk and maintain high liquidity of funds. All highly liquid investments with original maturities of three months or less at acquisition date are considered cash equivalents.

(e) Derivative instruments

The Company recognizes all derivative instruments as either assets or liabilities in the consolidated balance sheets at their respective fair values. The Company's derivative instruments, which are discussed in Notes 6 and 8, have been recorded as liabilities at fair value, and are revalued at each reporting date, with changes in the fair value of the instruments included in the consolidated statements of operations as non-operating income (expense).

(f) Revenue recognition

Revenue from patent licensing and enforcement is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. The Company uses management's best estimate of selling price for individual elements in multiple-element arrangements, where vendor specific evidence or third party evidence of selling price is not available.

Currently, the Company’s revenue arrangements provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met.

(g) Operating legal costs

Operating legal costs mainly include expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as internal payroll expenses and stock-based compensation.

(h) Recently Issued Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which provides guidance on the presentation of unrecognized tax benefits. This guidance requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows: to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This guidance is effective beginning January 1, 2014 and is to be applied prospectively with retroactive application permitted. The Company adopted this guidance as of January 1, 2014, as required. There was no material impact of the consolidated financial statements resulting from the adoption.

In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This guidance changes the criteria for reporting a discontinued operation while enhancing disclosures in this area. This standard will be effective for the Company beginning January 1, 2015. Early adoption of the standard is permitted, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available for issuance. The Company is currently evaluating the impact of the adoption on its consolidated financial statements.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which impacts virtually all aspects of an entity's revenue recognition. The core principle of the new standard is that revenue should be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance is effective for annual reporting periods beginning after December 15, 2016. The Company is currently evaluating the impact of the adoption on its consolidated financial statements.

In June 2014, the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation, which removes the definition of development stage entity, as was previously defined under U.S. GAAP, thereby removing the financial reporting distinction between development stage entities and other reporting entities. In addition, the ASU eliminates the requirements for development stage entities to (i) present inception-to-date information in their financial statements, (ii) label the financial statements as those of a development stage entity, (iii) disclose a description of the development stage activities in which the entity is engaged, and (iv) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This guidance is effective for annual reporting periods beginning after December 31, 2014 and early adoption of the standard is permitted. The Company adopted this guidance during the second quarter of 2014.

(i) Reclassification

Certain balances have been reclassified to conform to presentation requirements including discontinued operations.

Computation of Net Loss per Common Share

6 Months Ended

Jun. 30, 2014

Earnings Per Share, Basic and Diluted [Abstract]

Computation of Net Loss per Common Share

Note 3. Computation of Net Loss per Common Share

Basic net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. However, as the Company generated net losses in all periods presented, some potentially dilutive securities that relate to the continuing operations, including certain warrants and stock options, were not reflected in diluted net loss per share, because the impact of such instruments was anti-dilutive. The table below presents the computation of basic and diluted net losses per common share:

	Three months ended June 30,				Six months ended June 30,
	2014		2013		2014		2013
Basic Numerator:
Loss from continuing operations attributable to shares of common stock	$	(10,049)	$	(10,229)	$	(20,949)	$	(21,088)
Loss from discontinued operations attributable to shares of common stock		—		(711)	$	(209)	$	(1,816)
Net loss attributable to shares of common stock	$	(10,049)	$	(10,940)	$	(21,158)	$	(22,904)
Basic Denominator:
Weighted average number of shares of common stock outstanding during the period		87,210,483		82,625,295		86,337,006		82,406,883
Weighted average number of penny stock options		—		114,152		—		145,827
Basic common stock shares outstanding		87,210,483		82,739,447		86,337,006		82,552,710
Basic loss per common stock share from continuing operations	$	(0.12)	$	(0.12)	$	(0.24)	$	(0.26)
Basic loss per common stock share from discontinued operations	$	(0.00)		(0.01)	$	(0.00)	$	(0.02)
Basic net loss per common stock share	$	(0.12)	$	(0.13)	$	(0.24)	$	(0.28)

Diluted Numerator:
Net loss from continuing operations attributable to shares of common stock	$	(10,049)	$	(10,229)	$	(20,949)	$	(21,088)
Increase in net loss attributable to derivative warrants	$	(348)	$	—	$	—	$	—
Diluted net loss from continuing operations attributable to shares of common stock	$	(10,397)	$	(10,229)	$	(20,949)	$	(21,088)
Diluted net loss from discontinued operations attributable to shares of common stock	$	—	$	(711)	$	(209)	$	(1,816)
Diluted net loss attributable to shares of common stock	$	(10,397)	$	(10,940)	$	(21,158)	$	(22,904)

Diluted Denominator:
Basic common stock shares outstanding		87,210,483		82,739,447		86,337,006		82,552,710
Weighted average number of derivative warrants outstanding during the period		1,305,465		—		—		—
Diluted common stock shares outstanding		88,515,948		82,739,447		86,337,006		82,552,710
Diluted loss per common stock share from continuing operations	$	(0.12)	$	(0.12)	$	(0.24)	$	(0.26)
Diluted loss per common stock share from discontinued operations	$	(0.00)	$	(0.01)	$	(0.00)	$	(0.02)
Diluted net loss per common stock share	$	(0.12)	$	(0.13)	$	(0.24)	$	(0.28)

Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Both vested and unvested options at $0.96-$5.50 exercise price, to purchase an equal number of shares of common stock of the Company		10,102,094		11,805,940		10,102,094		11,805,940
Unvested penny options to purchase an equal number of shares of common stock of the Company		—		2,375		—		2,375
Unvested RSUs to issue an equal number of shares of common stock of the Company		1,657,890		2,815,794		1,657,890		2,815,794
Common stock shares granted, but not yet vested		—		61,478		—		61,478
Warrants to purchase an equal number of shares of common stock of the Company		15,801,923		18,764,114		17,423,851		18,764,114
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share		27,561,907		33,449,701		29,183,835		33,449,701

Discontinued Operations and Assets Held For Sale

6 Months Ended

Jun. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations and Assets Held For Sale

Note 4. Discontinued Operations and Assets Held For Sale

On December 31, 2013, the Company entered into a definitive asset purchase agreement with InfoMedia for the sale of all assets and the assignment of all agreements related to the Company’s mobile social application business. The closing of the transaction occurred on February 18, 2014 (“Closing”).

Upon Closing, as consideration for the assets and agreements related to the Company’s mobile social application business, the Company received 18 Class B shares of InfoMedia, which represent an 8.25% ownership interest in InfoMedia. Additionally, the Company’s Chief Executive Officer was appointed as a full voting member on InfoMedia’s board of directors and the Company received a number of customary protective rights. The InfoMedia Class B shares were accounted for as a cost-method investment at the carrying amount of $787 and are included in Other assets in the consolidated balance sheet as of June 30, 2014. During the six month period ended June 30, 2014, there were no events or changes in circumstances that would indicate that the carrying amount of this investment may no longer be recoverable.

In connection with the asset purchase agreement, the requirement to report the results of the Company’s mobile social application business as discontinued operations was triggered. The following tables represent the components of operating results from discontinued operations, as presented in the consolidated statements of operations:

	Three months ended June 30,
	2014		2013
Revenue	$	—	$	61
Operating expenses		—		(748)
Operating loss		—		(687)

Non-operating expense		—		(22)
Loss before taxes on income		—		(709)
Income tax expense		—		(2)
Loss from discontinued operations	$	—	$	(711)

	Six months ended June 30,
	2014		2013
Revenue	$	37	$	126
Operating expenses		(266)		(1,893)
Operating loss		(229)		(1,767)

Non-operating income (expense)		20		(31)
Loss before taxes on income		(209)		(1,798)
Income tax expense		—		(18)
Loss from discontinued operations	$	(209)	$	(1,816)

In addition, the following table presents the carrying amounts of the major classes of assets from the discontinued mobile social application business in the Company’s consolidated balance sheet as of December 31, 2013. These assets were transferred to InfoMedia upon Closing. As of December 31, 2013, there were no liabilities classified as held for sale and no liabilities were transferred to InfoMedia upon Closing.

	As of December 31,
	2013
Cash	$	48
Accounts receivable		102
Goodwill at carrying amount of $208, net of $208 loss on impairment		—
Acquired technology at carrying amount of $10,133, net of $2,451 accumulated amortization and $7,045 loss on impairment		637
Total assets held for sale	$	787

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

+ Details

Intangible Assets

6 Months Ended

Jun. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 5. Intangible Assets

	As of June 30, 2014		As of December 31, 2013		Weighted average amortization period (years)
Patents		28,213		28,213	8.3
Less: accumulated amortization		(7,390)		(5,465)
	$	20,823	$	22,748

The Company’s intangible assets consist of its patents which are amortized over their expected useful lives (i.e., through the expiration date of the patent). During the three and six month periods ended June 30, 2014, the Company recorded amortization expense of $968 and $1,925, respectively, related to its patents. During the three and six month periods ended June 30, 2013, the Company recorded amortization expense of $839 and $1,678, respectively, related to its patents.

Fair Value Measurements

6 Months Ended

Jun. 30, 2014

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 6. Fair Value Measurements

The Company measures fair value in accordance with FASB Accounting Standards Codification (“ASC”) 820-10, Fair Value Measurements and Disclosures. FASB ASC 820-10 clarifies that fair value is an exit price, representing the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, FASB ASC 820-10 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

Level 2: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

Level 3: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The following table presents the placement in the fair value hierarchy of liabilities measured at fair value on a recurring basis as of June 30, 2014 and December 31, 2013:

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
Derivative warrant liabilities	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
As of June 30, 2014	$	3,104		—		—	$	3,104
As of December 31, 2013	$	4,083		—		—	$	4,083

The Company measures its derivative liabilities at fair value. The Special Bridge Warrants, Conversion Warrants, the derivative Reload Warrants and the derivative Series 1 Warrants (as defined in Note 8) are classified within Level 3 because they are valued using the Black-Scholes-Merton and the Monte-Carlo models (as these warrants include down-round protection clauses), which utilize significant inputs that are unobservable in the market.

The following table presents the placement in the fair value hierarchy of assets that are measured at fair value on a non-recurring basis as of December 31, 2013 (there were no such assets or liabilities as of June 30, 2014):

Fair value measurement at reporting date using

Quoted prices in

active markets

Significant other

Significant

for identical

observable

unobservable

Balance

assets (Level 1)

inputs (Level 2)

inputs (Level 3)

Assets held for sale

787

150

—

637

In addition to the above, the Company’s financial instruments as of June 30, 2014 and December 31, 2013 consisted of cash, cash equivalents, receivables, accounts payable and deposits. The carrying amounts of all the aforementioned financial instruments approximate fair value. The following table summarizes the changes in the Company’s liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the six month period ended June 30, 2014:

	Level 3
Balance at December 31, 2013	$	4,083
Fair value adjustment, prior to exercise of warrants, included in Consolidated Statement of Operations		56
Exercise of derivative warrants		(1,707	)
Fair value adjustment at end of period, included in Consolidated Statement of Operations		672
Balance at June 30, 2014	$	3,104

Valuation processes for Level 3 Fair Value Measurements

Fair value measurement of the derivative warrant liabilities related to the Special Bridge Warrants, Conversion Warrants, Reload Warrants and Series 1 Warrants (as defined in Note 8) fall within Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

Description	Valuation technique	Unobservable inputs	Range
Special Bridge Warrants, Conversion Warrants, derivative	Black-Scholes-Merton and the	Volatility	32.83% – 46.41%
Reload Warrants and derivative Series 1 Warrants	Monte-Carlo models	Risk free interest rate	0.08% – 0.88%
		Expected term, in years	0.50 – 3.05
		Dividend yield	0%
		Probability and timing of down-round triggering event	5% occurrence in December 2014

The fair value of the assets held for sale as of December 31, 2013 (Note 4) was determined by estimating the present value of the expected future cash flows associated with that asset or asset group by using certain unobservable market inputs. These inputs included discount rates, estimated future cash flows and certain continuing growth rate assumptions. The discount rates are intended to reflect the risk inherent in the projected future cash flows generated by the respective asset or asset group. The inputs used in the valuation were sensitive to certain factors related to mobile social application technology such as rapid changes in the industry and technological advances.

Sensitivity of Level 3 measurements to changes in significant unobservable inputs

The inputs to estimate the fair value of the Company’s derivative warrant liabilities are the current market price of the Company’s common stock, the exercise price of the warrant, its remaining expected term, the volatility of the Company’s common stock price, the Company’s assumptions regarding the probability and timing of a down-round protection triggering event and the risk-free interest rate. Significant changes in any of those inputs in isolation can result in a significant change in the fair value measurement. Generally, an increase in the market price of the Company’s common stock, an increase in the volatility of the Company’s shares of common stock, an increase in the remaining term of the warrant, or an increase of a probability of a down-round triggering event would each result in a directionally similar change in the estimated fair value of the Company’s warrants. Such changes would increase the associated liability while decreases in these assumptions would decrease the associated liability. An increase in the risk-free interest rate or a decrease in the positive differential between the warrant’s exercise price and the market price of the Company’s shares of common stock would result in a decrease in the estimated fair value measurement of the warrants and thus a decrease in the associated liability. The Company has not, and does not plan to, declare dividends on its common stock, and as such, there is no change in the estimated fair value of the warrants due to the dividend assumption.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Stock-based Compensation

6 Months Ended

Jun. 30, 2014

Share-based Compensation [Abstract]

Stock-based Compensation

Note 7. Stock-based Compensation

The Company has a stock-based compensation plan available to grant stock options and RSU to the Company’s directors, employees and consultants. Under the 2012 Employee, Director and Consultant Equity Incentive Plan (the “Plan”), a maximum of 15,600,000 shares of common stock may be awarded. As of June 30, 2014, 3,741,170 shares were available for future grants under the Plan.

The following table illustrates the stock options granted for the six month period ended June 30, 2014:

Title

Grant date

No. of
options

Exercise
price

FMV at
grant date

Vesting terms

Assumptions used in
Black-Scholes option pricing
model

Directors, Management,
and Employees

January - June 2014

1,200,000

$ 3.12 - $ 4.10

$ 1.76 - $ 2.32

Over 1 year for
Directors; Over 3 years
for Management and
Employees

Volatility: 57.75 % – 62.00%
Risk free interest rate: 1.82% - 2.06%
Expected term, in years: 5.31-5.81
Dividend yield: 0.00%

Certain options granted to officers, directors and certain key employees are subject to acceleration of vesting of 75% - 100% (according to the agreement signed with each grantee), upon a subsequent change of control.

The activity related to stock options and RSU for the six month period ended June 30, 2014 consisted of the following:

	RSUs			Options
	No. of RSUs	Weighted average grant date fair value		No. of options	Weighted average exercise price		Exercise price range		Weighted average grant date fair value
Outstanding at January 1, 2014	2,161,403	$	3.61	10,457,159	$	3.23		$0.01 – $5.50	$	2.50
Granted	—		—	1,200,000	$	3.98		$3.12 - $4.10	$	2.16
Vested/Exercised	(500,388)	$	3.59	(1,126,815)	$	1.92		$0.01 – $3.72	$	1.31
Forfeited	(3,125)	$	3.72	(95,833)	$	3.71		$3.24 - $3.72	$	2.19
Expired	—		—	(332,416)	$	4.60		$0.96 – $5.50	$	1.97
Outstanding at June 30, 2014	1,657,890	$	3.62	10,102,095	$	3.41		$0.96 – $5.50	$	2.30
Exercisable at June 30, 2014	—		—	6,099,385	$	2.28		$0.96 – $5.50

The Company did not recognize tax benefits related to its stock-based compensation as there is a full valuation allowance recorded.

Warrants

6 Months Ended

Jun. 30, 2014

Warrants and Rights Note Disclosure [Abstract]

Warrants

Note 8. Warrants

The following table summarizes information about warrant activity for the six month period ended June 30, 2014:

	No. of warrants	Weighted average exercise price		Exercise price range
Outstanding at January 1, 2014	18,427,478	$	3.15		$0.94 – $5.06
Granted	5,412,366	$	5.06	$	5.06
Exercised	(6,415,992)	$	1.76	$	1.76
Outstanding at June 30, 2014	17,423,852	$	4.26		$0.94 – $5.06

On June 19, 2014, the Company entered into agreements with certain of its warrant holders, pursuant to which the warrant holders exercised for cash 5,697,227 of their outstanding Series 1 and Series 2 warrants, with an exercise price of $1.76 per share. The Company granted such warrant holders unregistered warrants of the Company to purchase an aggregate of 5,412,366 shares of the Company’s common stock, par value $0.01 per share, at an exercise price of $5.06 per share (the “June 2014 Warrants”). The June 2014 Warrants expire on June 21, 2015 and because such warrants do not bear any down-round protection clauses, they are classified as equity instruments. As a result of these transactions, the Company received $10,027 of proceeds.

The Company’s outstanding warrants consist of the following:

		No. outstanding classified as	No. outstanding classified as			Remaining
	No. outstanding	equity	liabilities*	Exercise price		contractual life
Series 1 Warrants	1,490,250	64,621	1,425,629	$	1.76	3.05 years
Series 2 Warrants	1,943,523	1,943,523	—	$	1.76	3.05 years
Conversion Warrants	14,492	—	14,492	$	0.94	0.98 years
Special Bridge Warrants	21,198	—	21,198	$	0.94	0.50 years
Reload Warrants	758,023	597,414	160,609	$	1.76	2.61 years
Initial Public Offering Warrants	4,784,000	4,784,000	—	$	5.06	0.98 years
October 2012 Warrants	3,000,000	3,000,000	—	$	5.06	0.98 years
June 2014 Warrants**	5,412,366	5,412,366	—	$	5.06	0.98 years
Outstanding at June 30, 2014	17,423,852	15,801,924	1,621,928

* These warrants bear down-round protection clauses and as a result, they are classified as derivative liabilities and recorded at fair value.

** The June 2014 Warrants were valued on the grant date (June 20, 2014) using the following assumptions: volatility: 40.05%, stock price: $3.33, risk free interest rate: 0.15% and dividend yield: 0%. The new warrants issued in connection with the exercise of warrants classified as liabilities were accounted for as an inducement and therefore an amount of $65, which is based on the fair value of the new warrants, was recorded as a non-operating expense during the second quarter of 2014. The new warrants issued in connection with the exercise of warrants classified as equity, which were fair valued at $611, were recorded as equity.

Revenue from Settlement and Licensing Agreement

6 Months Ended

Jun. 30, 2014

Revenue from Settlement and Licensing Agreement [Abstract]

Revenue from Settlement and Licensing Agreement

Note 9. Revenue from Settlements and Licensing Agreements

On April 28, 2014, the Company entered into a confidential agreement with Tyco that resolved all litigation pending between the parties.

Commitments and Contingencies

6 Months Ended

Jun. 30, 2014

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Note 10. Commitments and Contingencies

Litigation and legal proceedings

The Company retains the services of professional service providers, including law firms that specialize in intellectual property licensing, enforcement and patent law. These service providers are often retained on an hourly, monthly, project, contingent or a blended fee basis. In contingency fee arrangements, a portion of the legal fee is based on predetermined milestones or the Company’s actual collection of funds. The Company accrues contingent fees when it is probable that the milestones will be achieved and the fees can be reasonably estimated.

The Company’s subsidiaries have filed patent infringement lawsuits against the subsidiaries of ZTE Corporation in the United Kingdom, France, Germany, Australia, India, Brazil, Malaysia, and Romania, and against ASUSTeK Computer, Inc. and ASUS Computer GmbH in Germany, Spain and India. In such jurisdictions, an unsuccessful plaintiff may be required to pay a portion of the other party’s legal fees. Pursuant to negotiation with ZTE’s United Kingdom subsidiary, the Company made two written commitments, in November 2012 and May 2013, representing payment should a liability by Vringo Infrastructure arise as a result of the two cases it has filed. The defendants estimated the total possible liability to be no more than approximately $2,900 for each case. In addition, ZTE's German subsidiary started three revocation (invalidity) proceedings against the Company; two in the first half of 2013 and one in the first quarter of 2014. Should ZTE be successful in any of those actions, the Company would be liable for some portion of ZTE’s fees. The total amount the Company would have to pay is a statutorily determined percentage based on the estimated value in dispute for these proceedings. ZTE has estimated the value of the revocation proceeding at approximately $1,700 for each of the three revocation cases on file; the Company assesses the likelihood of such payment as remote. The value of each of the four infringement proceedings against ZTE on file and of each of the two infringement proceedings against ASUS on file has been estimated at approximately $1,400 by the Company. On May 5, 2014, the Company deposited a bond of approximately $1,400 to enforce an injunction against ZTE in Germany. Should the injunction be successfully overturned on appeal, the Company may be obligated to compensate ZTE for any damages allegedly suffered as a result of the enforcement of the injunction, which would be ascertained through separate damages proceedings. Should the judgment which granted the injunction be affirmed on appeal, however, the amount paid as security would be returnable to the Company in full.

Pursuant to negotiations with ZTE’s Australian subsidiary, the Company placed a written commitment in April 2014 to ensure payment should a liability by Vringo Infrastructure arise as a result of the case filed. The amount of such commitment cannot be reasonably estimated at this time and the Company assesses the likelihood of such payment as remote. In addition, in Brazil, as a condition of the relief requested, the Company deposited approximately $904 as a surety against the truth of allegations contained in the complaint. Unless ZTE is the prevailing party and proves that actual material damages were suffered while the requested relief was in place, the funds are returnable at the end of the litigation. The $1,400 bond deposit in Germany and the $904 surety deposit in Brazil are included in Deposits with courts in the consolidated balance sheet as of June 30, 2014.

In addition, the Company may be required to grant additional written commitments, as necessary, in connection with its commenced proceedings against ZTE Corporation and its subsidiaries in various countries. It should be noted, however, that if the Company were successful on any court applications or the entirety of any litigation, ZTE Corporation may be responsible for a substantial portion of the Company’s legal fees.

Leases

In July 2012, the Company signed a rental agreement for its corporate executive office in New York for an annual rental fee of approximately $137 (subject to certain adjustments) which was to expire in September 2015. However, in January 2014, the Company entered into an amended lease agreement with the landlord for a different office space within the same building. The initial annual rental fee for this new office is approximately $403 (subject to certain future escalations and adjustments) beginning when the new office space is available, which is expected to be in the third quarter of 2014. This lease will expire five years and three months after the new office space is available. Rent expense for operating leases for the three and six month periods ended June 30, 2014 were $70 and $182, respectively. Rent expense for operating leases for the three and six month periods ended June 30, 2013 were $63 and $107, respectively.

Risks and Uncertainties

6 Months Ended

Jun. 30, 2014

Risks and Uncertainties [Abstract]

Risks and Uncertainties

Note 11. Risks and Uncertainties

(a)

New legislation, regulations or rulings that impact the patent enforcement process or the rights of patent holders, could negatively affect the Company’s current business model. For example, limitations on the ability to bring patent enforcement claims, limitations on potential liability for patent infringement, lower evidentiary standards for invalidating patents, increases in the cost to resolve patent disputes and other similar developments could negatively affect the Company’s ability to assert its patent or other intellectual property rights.

(b)

The patents owned by the Company are presumed to be valid and enforceable. As part of the Company’s ongoing legal proceedings, the validity and/or enforceability of its patents is often challenged in a court or an administrative proceeding. To date, none of the Company’s patents have been declared to be invalid or unenforceable.

	(c)	Financial instruments which potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents with various major financial institutions. These major financial institutions are located in the United States and the Company’s policy is designed to limit exposure to any one institution.
	(d)	A portion of the Company’s expenses are denominated in foreign currencies. If the value of the U.S. dollar weakens against the value of these currencies, there will be a negative impact on the Company’s operating costs. In addition, the Company is subject to the risk of exchange rate fluctuations to the extent it holds monetary assets and liabilities in these currencies.

Accounting and Reporting Policies (Policies)

6 Months Ended

Jun. 30, 2014

Accounting Policies [Abstract]

Basis of presentation and principles of consolidation

(a) Basis of presentation and principles of consolidation

Use of estimates

(b) Use of estimates

Translation into U.S. dollars

(c) Translation into U.S. dollars

Cash and cash equivalents

(d) Cash and cash equivalents

Derivative instruments

(e) Derivative instruments

Revenue recognition

(f) Revenue recognition

Operating legal costs

(g) Operating legal costs

Recently Issued Accounting Pronouncements

(h) Recently Issued Accounting Pronouncements

Reclassification

(i) Reclassification

Certain balances have been reclassified to conform to presentation requirements including discontinued operations.

Computation of Net Loss per Common Share (Tables)

6 Months Ended

Jun. 30, 2014

Earnings Per Share, Basic and Diluted [Abstract]

Computation of Net Loss per Common Share

The table below presents the computation of basic and diluted net losses per common share:

	Three months ended June 30,				Six months ended June 30,
	2014		2013		2014		2013
Basic Numerator:
Loss from continuing operations attributable to shares of common stock	$	(10,049)	$	(10,229)	$	(20,949)	$	(21,088)
Loss from discontinued operations attributable to shares of common stock		—		(711)	$	(209)	$	(1,816)
Net loss attributable to shares of common stock	$	(10,049)	$	(10,940)	$	(21,158)	$	(22,904)
Basic Denominator:
Weighted average number of shares of common stock outstanding during the period		87,210,483		82,625,295		86,337,006		82,406,883
Weighted average number of penny stock options		—		114,152		—		145,827
Basic common stock shares outstanding		87,210,483		82,739,447		86,337,006		82,552,710
Basic loss per common stock share from continuing operations	$	(0.12)	$	(0.12)	$	(0.24)	$	(0.26)
Basic loss per common stock share from discontinued operations	$	(0.00)		(0.01)	$	(0.00)	$	(0.02)
Basic net loss per common stock share	$	(0.12)	$	(0.13)	$	(0.24)	$	(0.28)

Diluted Numerator:
Net loss from continuing operations attributable to shares of common stock	$	(10,049)	$	(10,229)	$	(20,949)	$	(21,088)
Increase in net loss attributable to derivative warrants	$	(348)	$	—	$	—	$	—
Diluted net loss from continuing operations attributable to shares of common stock	$	(10,397)	$	(10,229)	$	(20,949)	$	(21,088)
Diluted net loss from discontinued operations attributable to shares of common stock	$	—	$	(711)	$	(209)	$	(1,816)
Diluted net loss attributable to shares of common stock	$	(10,397)	$	(10,940)	$	(21,158)	$	(22,904)

Diluted Denominator:
Basic common stock shares outstanding		87,210,483		82,739,447		86,337,006		82,552,710
Weighted average number of derivative warrants outstanding during the period		1,305,465		—		—		—
Diluted common stock shares outstanding		88,515,948		82,739,447		86,337,006		82,552,710
Diluted loss per common stock share from continuing operations	$	(0.12)	$	(0.12)	$	(0.24)	$	(0.26)
Diluted loss per common stock share from discontinued operations	$	(0.00)	$	(0.01)	$	(0.00)	$	(0.02)
Diluted net loss per common stock share	$	(0.12)	$	(0.13)	$	(0.24)	$	(0.28)

Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Both vested and unvested options at $0.96-$5.50 exercise price, to purchase an equal number of shares of common stock of the Company		10,102,094		11,805,940		10,102,094		11,805,940
Unvested penny options to purchase an equal number of shares of common stock of the Company		—		2,375		—		2,375
Unvested RSUs to issue an equal number of shares of common stock of the Company		1,657,890		2,815,794		1,657,890		2,815,794
Common stock shares granted, but not yet vested		—		61,478		—		61,478
Warrants to purchase an equal number of shares of common stock of the Company		15,801,923		18,764,114		17,423,851		18,764,114
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share		27,561,907		33,449,701		29,183,835		33,449,701

Discontinued Operations and Assets Held For Sale (Tables)

6 Months Ended

Jun. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures

The following tables represent the components of operating results from discontinued operations, as presented in the consolidated statements of operations:

	Three months ended June 30,
	2014		2013
Revenue	$	—	$	61
Operating expenses		—		(748)
Operating loss		—		(687)

Non-operating expense		—		(22)
Loss before taxes on income		—		(709)
Income tax expense		—		(2)
Loss from discontinued operations	$	—	$	(711)

	Six months ended June 30,
	2014		2013
Revenue	$	37	$	126
Operating expenses		(266)		(1,893)
Operating loss		(229)		(1,767)

Non-operating income (expense)		20		(31)
Loss before taxes on income		(209)		(1,798)
Income tax expense		—		(18)
Loss from discontinued operations	$	(209)	$	(1,816)

	As of December 31,
	2013
Cash	$	48
Accounts receivable		102
Goodwill at carrying amount of $208, net of $208 loss on impairment		—
Acquired technology at carrying amount of $10,133, net of $2,451 accumulated amortization and $7,045 loss on impairment		637
Total assets held for sale	$	787

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Components of Finite-Lived Intangible Assets

	As of June 30, 2014		As of December 31, 2013		Weighted average amortization period (years)
Patents		28,213		28,213	8.3
Less: accumulated amortization		(7,390)		(5,465)
	$	20,823	$	22,748

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2014

Fair Value Measurements [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the placement in the fair value hierarchy of liabilities measured at fair value on a recurring basis as of June 30, 2014 and December 31, 2013:

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
Derivative warrant liabilities	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
As of June 30, 2014	$	3,104		—		—	$	3,104
As of December 31, 2013	$	4,083		—		—	$	4,083

Assets and Liabilities Measured at Fair Value on Nonrecurring Basis

Fair value measurement at reporting date using

Quoted prices in

active markets

Significant other

Significant

for identical

observable

unobservable

Balance

assets (Level 1)

inputs (Level 2)

inputs (Level 3)

Assets held for sale

787

150

—

637

Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs

The following table summarizes the changes in the Company’s liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the six month period ended June 30, 2014:

	Level 3
Balance at December 31, 2013	$	4,083
Fair value adjustment, prior to exercise of warrants, included in Consolidated Statement of Operations		56
Exercise of derivative warrants		(1,707	)
Fair value adjustment at end of period, included in Consolidated Statement of Operations		672
Balance at June 30, 2014	$	3,104

Fair Value Measurements Based Upon Sensitivity and Nature of Inputs

The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

Description	Valuation technique	Unobservable inputs	Range
Special Bridge Warrants, Conversion Warrants, derivative	Black-Scholes-Merton and the	Volatility	32.83% – 46.41%
Reload Warrants and derivative Series 1 Warrants	Monte-Carlo models	Risk free interest rate	0.08% – 0.88%
		Expected term, in years	0.50 – 3.05
		Dividend yield	0%
		Probability and timing of down-round triggering event	5% occurrence in December 2014

Stock-based Compensation (Tables)

6 Months Ended

Jun. 30, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Options and Restricted Stock Units Activity

The activity related to stock options and RSU for the six month period ended June 30, 2014 consisted of the following:

	RSUs			Options
	No. of RSUs	Weighted average grant date fair value		No. of options	Weighted average exercise price		Exercise price range		Weighted average grant date fair value
Outstanding at January 1, 2014	2,161,403	$	3.61	10,457,159	$	3.23		$0.01 – $5.50	$	2.50
Granted	—		—	1,200,000	$	3.98		$3.12 - $4.10	$	2.16
Vested/Exercised	(500,388)	$	3.59	(1,126,815)	$	1.92		$0.01 – $3.72	$	1.31
Forfeited	(3,125)	$	3.72	(95,833)	$	3.71		$3.24 - $3.72	$	2.19
Expired	—		—	(332,416)	$	4.60		$0.96 – $5.50	$	1.97
Outstanding at June 30, 2014	1,657,890	$	3.62	10,102,095	$	3.41		$0.96 – $5.50	$	2.30
Exercisable at June 30, 2014	—		—	6,099,385	$	2.28		$0.96 – $5.50

Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Options Granted

The following table illustrates the stock options granted for the six month period ended June 30, 2014:

Title

Grant date

No. of
options

Exercise
price

FMV at
grant date

Vesting terms

Assumptions used in
Black-Scholes option pricing
model

Directors, Management,
and Employees

January - June 2014

1,200,000

$ 3.12 - $ 4.10

$ 1.76 - $ 2.32

Over 1 year for
Directors; Over 3 years
for Management and
Employees

Volatility: 57.75 % – 62.00%
Risk free interest rate: 1.82% - 2.06%
Expected term, in years: 5.31-5.81
Dividend yield: 0.00%

Warrants (Tables)

6 Months Ended

Jun. 30, 2014

Warrants and Rights Note Disclosure [Abstract]

Schedule Of Changes In Warrants Activity

The following table summarizes information about warrant activity for the six month period ended June 30, 2014:

	No. of warrants	Weighted average exercise price		Exercise price range
Outstanding at January 1, 2014	18,427,478	$	3.15		$0.94 – $5.06
Granted	5,412,366	$	5.06	$	5.06
Exercised	(6,415,992)	$	1.76	$	1.76
Outstanding at June 30, 2014	17,423,852	$	4.26		$0.94 – $5.06

Schedule Of Warrants Outstanding

The Company’s outstanding warrants consist of the following:

		No. outstanding classified as	No. outstanding classified as			Remaining
	No. outstanding	equity	liabilities*	Exercise price		contractual life
Series 1 Warrants	1,490,250	64,621	1,425,629	$	1.76	3.05 years
Series 2 Warrants	1,943,523	1,943,523	—	$	1.76	3.05 years
Conversion Warrants	14,492	—	14,492	$	0.94	0.98 years
Special Bridge Warrants	21,198	—	21,198	$	0.94	0.50 years
Reload Warrants	758,023	597,414	160,609	$	1.76	2.61 years
Initial Public Offering Warrants	4,784,000	4,784,000	—	$	5.06	0.98 years
October 2012 Warrants	3,000,000	3,000,000	—	$	5.06	0.98 years
June 2014 Warrants**	5,412,366	5,412,366	—	$	5.06	0.98 years
Outstanding at June 30, 2014	17,423,852	15,801,924	1,621,928

* These warrants bear down-round protection clauses and as a result, they are classified as derivative liabilities and recorded at fair value.

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

General (Additional Information) (Details)	Feb. 18, 2014
Cost Method Investment Ownership Percentage	8.25%

Computation of Net Loss per Common Share (Computation of basic and diluted net losses per common share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Earnings Per Share Disclosure [Line Items]
Loss from continuing operations attributable to shares of common stock	$ (10,049)	$ (10,229)	$ (20,949)	$ (21,088)
Loss from discontinued operations attributable to shares of common stock	0	(711)	(209)	(1,816)
Net loss attributable to shares of common stock	$ (10,049)	$ (10,940)	$ (21,158)	$ (22,904)
Basic common stock shares outstanding	87,210,483	82,739,447	86,337,006	82,552,710
Basic loss per common stock share from continuing operations	$ (0.12)	$ (0.12)	$ (0.24)	$ (0.26)
Basic loss per common stock share from discontinued operations	(0.00)	(0.01)	(0.00)	(0.02)
Basic net loss per common stock share	$ (0.12)	$ (0.13)	$ (0.24)	$ (0.28)
Diluted common stock shares outstanding	88,515,948	82,739,447	86,337,006	82,552,710
Diluted loss per common stock share from discontinued operations	$ (0.00)	$ (0.01)	$ (0.00)	$ (0.02)
Diluted net loss per common stock share	$ (0.12)	$ (0.13)	$ (0.24)	$ (0.28)
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	27,561,907	33,449,701	29,183,835	33,449,701
Basic Numerator [Member]
Earnings Per Share Disclosure [Line Items]
Loss from continuing operations attributable to shares of common stock	$ (10,049)	$ (10,229)	$ (20,949)	$ (21,088)
Loss from discontinued operations attributable to shares of common stock	0	(711)	(209)	(1,816)
Net loss attributable to shares of common stock	$ (10,049)	$ (10,940)	$ (21,158)	$ (22,904)
Basic Denominator [Member]
Earnings Per Share Disclosure [Line Items]
Weighted average number of shares of common stock outstanding during the period	87,210,483	82,625,295	86,337,006	82,406,883
Weighted average number of penny stock options	0	114,152	0	145,827
Basic common stock shares outstanding	87,210,483	82,739,447	86,337,006	82,552,710
Basic loss per common stock share from continuing operations	$ (0.12)	$ (0.12)	$ (0.24)	$ (0.26)
Basic loss per common stock share from discontinued operations	(0.00)	(0.01)	(0.00)	(0.02)
Basic net loss per common stock share	$ (0.12)	$ (0.13)	$ (0.24)	$ (0.28)
Diluted Numerator [Member]
Earnings Per Share Disclosure [Line Items]
Loss from continuing operations attributable to shares of common stock	$ (10,049)	$ (10,229)	$ (20,949)	$ (21,088)
Increase in net loss attributable to derivative warrants	(348)	0	0	0
Diluted net loss from continued operations attributable to shares of common stock	(10,397)	(10,229)	(20,949)	(21,088)
Diluted net loss from discontinued operations attributable to shares of common stock	0	(711)	(209)	(1,816)
Diluted net loss attributable to shares of common stock	$ (10,397)	$ (10,940)	$ (21,158)	$ (22,904)
Diluted Denominator [Member]
Earnings Per Share Disclosure [Line Items]
Basic common stock shares outstanding	87,210,483	82,739,447	86,337,006	82,552,710
Weighted average number of derivative warrants outstanding during the period	1,305,465	0	0	0
Diluted common stock shares outstanding	88,515,948	82,739,447	86,337,006	82,552,710
Diluted loss per common stock share from continuing operations	$ (0.12)	$ (0.12)	$ (0.24)	$ (0.26)
Diluted loss per common stock share from discontinued operations	(0.00)	(0.01)	(0.00)	(0.02)
Diluted net loss per common stock share	$ (0.12)	$ (0.13)	$ (0.24)	$ (0.28)
Vested and unvested options at $0.96-$5.50 exercise price [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	10,102,094	11,805,940	10,102,094	11,805,940
Unvested penny options [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	0	2,375	0	2,375
Unvested Restricted Stock Units (“RSU”) [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	1,657,890	2,815,794	1,657,890	2,815,794
Common stock shares granted, but not yet vested [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	0	61,478	0	61,478
Warrants to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	15,801,923	18,764,114	17,423,851	18,764,114

Computation of Net Loss per Common Share (Parenthetical) (Details) - $ / shares	Jun. 30, 2014	Dec. 31, 2013
Earnings Per Share Disclosure [Line Items]
Stock Option Exercise Price	$ 3.41	$ 3.23
Maximum [Member]
Earnings Per Share Disclosure [Line Items]
Stock Option Exercise Price	5.50	5.50
Minimum [Member]
Earnings Per Share Disclosure [Line Items]
Stock Option Exercise Price	$ 0.96	$ 0.01

Discontinued Operations and Assets Held For Sale (Disposal Group Not Discontinued Operation Income Statement Disclosures) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	$ 0	$ 61	$ 37	$ 126
Operating expenses	0	(748)	(266)	(1,893)
Operating loss	0	(687)	(229)	(1,767)
Non-operating income (expense)	0	(22)	20	(31)
Loss before taxes on income	0	(709)	(209)	(1,798)
Income tax expense	0	(2)	0	(18)
Loss from discontinued operations	$ 0	$ (711)	$ (209)	$ (1,816)

Discontinued Operations and Assets Held For Sale (Details) - USD ($) $ in Thousands	Jun. 30, 2014	Dec. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash		$ 48
Accounts receivable		102
Goodwill at carrying amount of $208, net of $208 loss on impairment		0
Acquired technology at carrying amount of $10,133, net of $2,451 accumulated amortization and $7,045 loss on impairment		637
Total assets held for sale	$ 0	$ 787

Discontinued Operations and Assets Held For Sale (Parenthetical) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Jun. 30, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Goodwill, Gross	$ 208
Goodwill, Impairment Loss	208
Finite-Lived Intangible Assets, Gross	28,213	$ 28,213
Finite-Lived Intangible Assets, Accumulated Amortization	5,465	$ 7,390
Acquired Technology [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Finite-Lived Intangible Assets, Gross	10,133
Finite-Lived Intangible Assets, Accumulated Amortization	2,451
Impairment of Intangible Assets, Finite-lived	$ 7,045

Discontinued Operations and Assets Held For Sale (Additional Information) (Details) - USD ($) $ in Thousands	Jun. 30, 2014	Feb. 18, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cost Method Investment Ownership Percentage		8.25%
Infomedia [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cost Method Investment Ownership Percentage		8.25%
Cost Method Investments	$ 787

Intangible Assets (Schedule of Finite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Patents	$ 28,213	$ 28,213
Less: accumulated amortization	(7,390)	(5,465)
Finite-Lived Intangible Assets, Net	$ 20,823	$ 22,748
Weighted average amortization period (years)	8 years 3 months 18 days

Intangible Assets (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 968	$ 839	$ 1,925	$ 1,678
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 968	$ 839	$ 1,925	$ 1,678

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	Jun. 30, 2014	Dec. 31, 2013
Liabilities
Derivative warrant liabilities	$ 3,104	$ 4,083
Fair Value, Inputs, Level 1 [Member]
Liabilities
Derivative warrant liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities
Derivative warrant liabilities	0	0
Fair Value Inputs Level 3 [Member]
Liabilities
Derivative warrant liabilities	$ 3,104	$ 4,083

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on Nonrecurring Basis) (Details) - USD ($) $ in Thousands	Jun. 30, 2014	Dec. 31, 2013
Fair Value Assets and Liabilities Measured On Nonrecurring Basis [Line Items]
Assets held for sale	$ 0	$ 787
Fair Value, Inputs, Level 1 [Member]
Fair Value Assets and Liabilities Measured On Nonrecurring Basis [Line Items]
Assets held for sale		150
Fair Value, Inputs, Level 2 [Member]
Fair Value Assets and Liabilities Measured On Nonrecurring Basis [Line Items]
Assets held for sale		0
Fair Value Inputs Level 3 [Member]
Fair Value Assets and Liabilities Measured On Nonrecurring Basis [Line Items]
Assets held for sale		$ 637

Fair Value Measurements (Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2014 USD ($)
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Opening balance	$ 4,083
Fair value adjustment, prior to exercise of warrants, included in Consolidated Statement of Operations	56
Exercise of derivative warrants	(1,707)
Fair value adjustment at end of period, included in Consolidated Statement of Operations	672
Closing balance	$ 3,104

Fair Value Measurements (Based Upon Sensitivity and Nature of Inputs) (Details)	6 Months Ended
	Jun. 30, 2014
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Dividend yield	0.00%
Probability of down-round triggering event	5.00%
Timing of down-round triggering event	December 2014
Minimum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	32.83%
Risk free interest rate	0.08%
Expected term, in years	6 months
Maximum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	46.41%
Risk free interest rate	0.88%
Expected term, in years	3 years 18 days

Stock-based Compensation (Schedule Of Common Stock Option Granted) (Details) - $ / shares	6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Stockholders Equity [Line Items]
No. of options	1,200,000
Exercise price	$ 3.41	$ 3.23
FMV at grant date	2.16
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price	5.50	5.50
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 0.96	$ 0.01
Management Directors and Employees [Member]
Stockholders Equity [Line Items]
Grant Date	January - June 2014
No. of options	1,200,000
Vesting terms	Over 1 year for Directors; Over 3 years for Management and Employees
Volatility Rate, Minimum	57.75%
Volatility Rate, Maximum	62.00%
Risk free interest rate, Minimum	1.82%
Risk free interest rate, Maximum	2.06%
Dividend yield	0.00%
Management Directors and Employees [Member] \| Maximum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 4.10
FMV at grant date	$ 2.32
Expected term, in years	5 years 9 months 22 days
Management Directors and Employees [Member] \| Minimum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 3.12
FMV at grant date	$ 1.76
Expected term, in years	5 years 3 months 22 days

Stock-based Compensation (Option Activity) (Details)	6 Months Ended
Stock-based Compensation (Option Activity) (Details)	Jun. 30, 2014 $ / shares shares
Stockholders Equity [Line Items]
No. of options, Outstanding at January 1, 2014 \| shares	10,457,159
Granted \| shares	1,200,000
No. of options, Vested/Exercised \| shares	(1,126,815)
No. of options, Forfeited \| shares	(95,833)
No. of options, Expired \| shares	(332,416)
No. of options, Outstanding at June 30, 2014 \| shares	10,102,095
No. of options, Exercisable at June 30, 2014 \| shares	6,099,385
Exercise price range, Outstanding at January 1, 2014	$ 3.23
Exercise price range, Granted	3.98
Exercise price range, Vested/Exercised	1.92
Exercise price range, Forfeited	3.71
Exercise price range, Expired	4.60
Exercise price range, Outstanding June 30, 2014	3.41
Exercise price range, Exercisable at June 30, 2014	2.28
Weighted average grant date fair value, Outstanding at January 1, 2014	2.50
Weighted average grant date fair value, Granted	2.16
Weighted average grant date fair value, Vested/Exercised	1.31
Weighted average grant date fair value, Forfeited	2.19
Weighted average grant date fair value, Expired	1.97
Weighted average grant date fair value, Outstanding at June 30, 2014	$ 2.30
Restricted Stock [Member]
Stockholders Equity [Line Items]
No of RSUs Outstanding at January 1, 2014 \| shares	2,161,403
No. of RSUs, Granted \| shares	0
No. of RSUs, Vested/Exercised \| shares	(500,388)
No. of RSUs, Forfeited \| shares	(3,125)
No. of RSUs, Expired \| shares	0
No. of RSUs, Outstanding at June 30, 2014 \| shares	1,657,890
No. of RSUs, Exercisable at June 30, 2014 \| shares	0
Weighted average grant date fair value Outstanding at January 1, 2014	$ 3.61
Weighted average grant date fair value, Granted	0
Weighted average grant date fair value, Vested/Exercised	3.59
Weighted average grant date fair value, Forfeited	3.72
Weighted average grant date fair value, Expired	0
Weighted average grant date fair value, Outstanding at June 30, 2014	3.62
Weighted average grant date fair value, Exercisable at June 30, 2014	0
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding at January 1, 2014	0.01
Exercise price range, Granted	3.12
Exercise price range, Vested/Exercised	0.01
Exercise price range, Forfeited	3.24
Exercise price range, Expired	0.96
Exercise price range, Outstanding June 30, 2014	0.96
Exercise price range, Exercisable at June 30, 2014	0.96
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding at January 1, 2014	5.50
Exercise price range, Granted	4.10
Exercise price range, Vested/Exercised	3.72
Exercise price range, Forfeited	3.72
Exercise price range, Expired	5.50
Exercise price range, Outstanding June 30, 2014	5.50
Exercise price range, Exercisable at June 30, 2014	$ 5.50

Stock-based Compensation (Additional Information) (Detail)	6 Months Ended
	Jun. 30, 2014 shares
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	3,741,170
Maximum [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100.00%
Minimum [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	75.00%
Two Thousand Twelve Stock Option Plan [Member] \| Maximum [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period	15,600,000

Warrants (Schedule Of Changes In Warrants Activity) (Details) - Warrant [Member] shares in Thousands	6 Months Ended
	Jun. 30, 2014 $ / shares shares
No of RSUs Outstanding at January 1, 2014 \| shares	18,427,478
Granted \| shares	5,412,366
Exercised \| shares	(6,415,992)
No. of RSUs, Outstanding at June 30, 2014 \| shares	17,423,852
Outstanding at January, Weighted average exercise price	$ 3.15
Granted, Weighted average exercise price	5.06
Exercised, Weighted average exercise price	1.76
Outstanding at January, Weighted average exercise price	4.26
Granted, Exercise price range	5.06
Exercised, Exercise price range	1.76
Maximum [Member]
Outstanding At January, Exercise price range	5.06
Outstanding At January, Exercise price range	5.06
Minimum [Member]
Outstanding At January, Exercise price range	0.94
Outstanding At January, Exercise price range	$ 0.94

Warrants (Schedule of Warrants Outstanding) (Details)
shares in Thousands

6 Months Ended

Jun. 30, 2014

$ / shares

Warrant outstanding

17,423,852

Class of Warrant or Right Number of Equity Called by Warrants or Rights

15,801,924

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

1,621,928

^[1]

Series 1 Warrants [Member]

Warrant outstanding

1,490,250

Class of Warrant or Right Number of Equity Called by Warrants or Rights

64,621

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

1,425,629

^[1]

Exercise Price | $ / shares

$ 1.76

Expected Term Of Warrants

3 years 18 days

Series 2 Warrants [Member]

Warrant outstanding

1,943,523

Class of Warrant or Right Number of Equity Called by Warrants or Rights

1,943,523

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

^[1]

Exercise Price | $ / shares

$ 1.76

Expected Term Of Warrants

3 years 18 days

Conversion Warrants [Member]

Warrant outstanding

14,492

Class of Warrant or Right Number of Equity Called by Warrants or Rights

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

14,492

^[1]

Exercise Price | $ / shares

$ 0.94

Expected Term Of Warrants

11 months 23 days

Special Bridge Warrants [Member]

Warrant outstanding

21,198

Class of Warrant or Right Number of Equity Called by Warrants or Rights

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

21,198

^[1]

Exercise Price | $ / shares

$ 0.94

Expected Term Of Warrants

6 months

Reload Warrants [Member]

Warrant outstanding

758,023

Class of Warrant or Right Number of Equity Called by Warrants or Rights

597,414

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

160,609

^[1]

Exercise Price | $ / shares

$ 1.76

Expected Term Of Warrants

2 years 7 months 10 days

Initial Public Offering Warrant [Member]

Warrant outstanding

4,784,000

Class of Warrant or Right Number of Equity Called by Warrants or Rights

4,784,000

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

^[1]

Exercise Price | $ / shares

$ 5.06

Expected Term Of Warrants

11 months 23 days

October 2012 Warrants [Member]

Warrant outstanding

3,000,000

Class of Warrant or Right Number of Equity Called by Warrants or Rights

3,000,000

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

^[1]

Exercise Price | $ / shares

$ 5.06

Expected Term Of Warrants

11 months 23 days

June 2014 Warrants [Member]

Warrant outstanding

5,412,366

^[2]

Class of Warrant or Right Number of Equity Called by Warrants or Rights

5,412,366

^[2]

Class of Warrant or Right, Number of Liabilities Called by Each Warrant or Right

^[1],[2]

Exercise Price | $ / shares

$ 5.06

^[2]

Expected Term Of Warrants

11 months 23 days

^[2]

[1]

These warrants bear down-round protection clauses and as a result, they are classified as derivative liabilities and recorded at fair value.

[2]

The June 2014 Warrants were valued on the grant date (June 20, 2014) using the following assumptions: volatility: 40.05%, stock price: $3.33, risk free interest rate: 0.15% and dividend yield: 0%. The new warrants issued in connection with the exercise of warrants classified as liabilities were accounted for as an inducement and therefore an amount of $65, which is based on the fair value of the new warrants, was recorded as a non-operating expense during the second quarter of 2014. The new warrants issued in connection with the exercise of warrants classified as equity, which were fair valued at $611, were recorded as equity.

Warrants (Schedule of Warrants Outstanding) (Parenthetical) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended
	Jun. 19, 2014	Jun. 30, 2014
Fair Value Assumptions Expected Dividend Rate		0.00%
Warrants and Rights Outstanding	$ 611
Warrant [Member]
Share Price	$ 3.33
Fair Value Assumptions Expected Volatility Rate	40.05%
Fair Value Assumptions Risk Free Interest Rate	0.15%
Fair Value Assumptions Expected Dividend Rate	0.00%
Income Loss From Issuance Of Inducement Warrant	$ 65

Warrants (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended
	Jun. 19, 2014	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Common Stock, Shares, Outstanding		92,545,862		84,502,653
Common stock, par value		$ 0.01		$ 0.01
Proceeds From Warrant Exercises	$ 10,027	$ 11,292	$ 174
Investment Warrants Expiration Date		Jun. 21, 2015
Warrant [Member]
Common Stock, Shares, Outstanding	5,697,227
Exercise Price	$ 1.76
Warrant [Member] \| Innovate Protect Inc [Member]
Exercise Price	$ 5.06
Warrants Issued	5,412,366
Common stock, par value		$ 0.01

Commitments And Contingencies (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	May 05, 2014	May 31, 2013	Nov. 30, 2012
Finite-Lived Intangible Assets [Line Items]
Rental expense for operating leases	$ 70	$ 63	$ 182	$ 107
Revocation Proceeding Value			1,700
Infringement Proceeding Value			1,400
Deposited Amount For Surety Against Truth Of Allegations			904
Litigation Settlement Deposit Amount					$ 1,400
Until Renovation Of Building [Member]
Finite-Lived Intangible Assets [Line Items]
Operating Lease Rent Expense Annual Fee			403
Maximum [Member] \| Written Commitment One [Member]
Finite-Lived Intangible Assets [Line Items]
Guarantee placed for contingent loss in litigation						$ 2,900
Maximum [Member] \| Written Commitment Two [Member]
Finite-Lived Intangible Assets [Line Items]
Guarantee placed for contingent loss in litigation							$ 2,900
New York [Member]
Finite-Lived Intangible Assets [Line Items]
Operating Lease Rent Expense Annual Fee			$ 137